Production of SARS-CoV-2 pseudotyped viral particles for the evaluation of new therapies against COVID-19. (2022). FAVE Sección Ciencias Veterinarias, 20(Suppl.), 44-50. https://doi.org/10.14409/favecv.2021.Suppl..44-50